The next phase of a billion-pound city regeneration scheme has been revealed.
by Rory Butler / December 5, 2022
Conygar Investment Company has submitted plans for the next phase of The Island Quarter, a £1 billion mixed-use development in Nottingham – which will include a new bioscience building.
- two buildings (five and seven storeys)
- 249,000 sq ft bioscience facility
- laboratories and office space
It forms part of a wider masterplan to redevelop 36 acres in the city, formally the site of the old Boots pharmaceutical factory.
To date, The Island Quarter has seen new restaurants and an events venue, and construction of a 693-bed student scheme is due for completion in 2024.
Nottingham City Council granted permission in May for the next phase:
- 247 build-to-rent flats
- 223-room hotel
- 400 co-work stations
On the job:
- Sir Robert McAlpine
- Dodd Group
- CPMG Architects
McAlpine said 40% of Phase One spending will be within 20 miles of Nottingham.
“Nottingham is already home to a large number of exciting businesses in the bioscience space and this scheme will be an excellent addition to the mixed-use development we are creating at The Island Quarter,” said Christopher Ware, Property Director of Conygar.
If you enjoyed this article, we also recommend Inside £70m ‘Hollywood of the North’ deal
